Naloxone Hydrochloride Patent Expiration
Naloxone Hydrochloride is used for the emergency treatment of opioid overdose to reverse respiratory and central nervous system depression. It was first introduced by Adapt Pharma Operations Ltd
Naloxone Hydrochloride Patents
Given below is the list of patents protecting Naloxone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zimhi | US11571518 | Emergency devices | Jun 14, 2041 | Zmi Pharma |
| Zimhi | US11027072 | Emergency devices | May 24, 2039 | Zmi Pharma |
| Evzio | US10220158 | Devices and methods for delivering opioid antagonists including formulations for naloxone | Mar 20, 2035 | Kaleo Inc |
| Evzio (autoinjector) | US10220158 | Devices and methods for delivering opioid antagonists including formulations for naloxone | Mar 20, 2035 | Kaleo Inc |
| Narcan | US10085937 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9211253 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9468747 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9480644 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9561177 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9629965 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9707226 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Narcan | US9775838 | Nasal drug products and methods of their use | Mar 16, 2035 | Emergent |
| Kloxxado | US10722510 | Liquid naloxone spray | Aug 26, 2034 | Hikma |
| Kloxxado | US10973814 | Liquid naloxone spray | Aug 26, 2034 | Hikma |
| Kloxxado | US11135155 | Liquid naloxone spray | Aug 26, 2034 | Hikma |
| Kloxxado | US11617713 | Liquid naloxone spray | Aug 26, 2034 | Hikma |
| Kloxxado | US11628139 | Liquid naloxone spray | Aug 26, 2034 | Hikma |
| Evzio | US9517307 | Devices and methods for delivering opioid antagonists including formulations for naloxone | Jul 18, 2034 | Kaleo Inc |
| Evzio (autoinjector) | US9517307 | Devices and methods for delivering opioid antagonists including formulations for naloxone | Jul 18, 2034 | Kaleo Inc |
| Rivive | US11020343 | Intranasal pharmaceutical dosage forms comprising naloxone | May 11, 2032 | Harm Reduction Therp |
| Rivive | US11806428 | Intranasal pharmaceutical dosage forms comprising naloxone | May 11, 2032 | Harm Reduction Therp |
| Evzio | US8627816 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 04, 2032 | Kaleo Inc |
| Evzio (autoinjector) | US8627816 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 04, 2032 | Kaleo Inc |
| Evzio | US10143972 | Ultrafiltration membrane and a preparation method thereof | May 24, 2031 | Kaleo Inc |
| Evzio (autoinjector) | US10143792 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | May 24, 2031 | Kaleo Inc |
| Evzio (autoinjector) | US10143972 | Ultrafiltration membrane and a preparation method thereof | May 24, 2031 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US10143792 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | May 24, 2031 | Kaleo Inc |
| Evzio | US10322239 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio | US8939943 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio | US9022022 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio | US9474869 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio (autoinjector) | US10322239 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio (autoinjector) | US8939943 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio (autoinjector) | US9022022 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio (autoinjector) | US9474869 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US10322239 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US8939943 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US9022022 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US9474869 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US9814838 | Medicament delivery device for administration of opioid antagonists including formulations for naloxone | Feb 28, 2031 | Kaleo Inc |
| Evzio | US8021344 | Medicament delivery device configured to produce an audible output | Nov 02, 2029 | Kaleo Inc |
| Evzio (autoinjector) | US8021344 | Medicament delivery device configured to produce an audible output | Nov 02, 2029 | Kaleo Inc |
| Evzio | US8223610 | Apparatus and method for initializing information recording medium, apparatus and method for recording information, and information recording medium | Apr 10, 2029 | Kaleo Inc |
| Evzio | US8226610 | Medical injector with compliance tracking and monitoring | Apr 10, 2029 | Kaleo Inc |
| Evzio (autoinjector) | US8226610 | Medical injector with compliance tracking and monitoring | Apr 10, 2029 | Kaleo Inc |
| Evzio | US8231573 | Medicament delivery device having an electronic circuit system | Nov 25, 2028 | Kaleo Inc |
| Evzio (autoinjector) | US8231573 | Medicament delivery device having an electronic circuit system | Nov 25, 2028 | Kaleo Inc |
| Evzio | US7749194 | Devices, systems, and methods for medicament delivery | Oct 30, 2028 | Kaleo Inc |
| Evzio (autoinjector) | US7749194 | Devices, systems, and methods for medicament delivery | Oct 30, 2028 | Kaleo Inc |
| Evzio | US7947017 | Devices, systems and methods for medicament delivery | Mar 12, 2028 | Kaleo Inc |
| Evzio (autoinjector) | US7947017 | Devices, systems and methods for medicament delivery | Mar 12, 2028 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US7947017 | Devices, systems and methods for medicament delivery | Mar 12, 2028 | Kaleo Inc |
| Evzio | US9724471 | Devices, systems, and methods for medicament delivery | May 23, 2027 | Kaleo Inc |
| Evzio (autoinjector) | US9724471 | Devices, systems, and methods for medicament delivery | May 23, 2027 | Kaleo Inc |
| Evzio | US8206360 | Devices, systems and methods for medicament delivery | Feb 27, 2027 | Kaleo Inc |
| Evzio (autoinjector) | US8206360 | Devices, systems and methods for medicament delivery | Feb 27, 2027 | Kaleo Inc |
| Evzio | US9238108 | Medicament delivery device having an electronic circuit system | Feb 20, 2027 | Kaleo Inc |
| Evzio (autoinjector) | US9238108 | Medicament delivery device having an electronic circuit system | Feb 20, 2027 | Kaleo Inc |
| Evzio | US11590286 | Devices, systems and methods for medicament delivery | Dec 12, 2026 | Kaleo Inc |
| Evzio (autoinjector) | US11590286 | Devices, systems and methods for medicament delivery | Dec 12, 2026 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US11590286 | Devices, systems and methods for medicament delivery | Dec 12, 2026 | Kaleo Inc |
| Evzio | US10960155 | Devices, systems and methods for medicament delivery | Jun 25, 2026 | Kaleo Inc |
| Evzio (autoinjector) | US10960155 | Devices, systems and methods for medicament delivery | Jun 25, 2026 | Kaleo Inc |
| Evzio | US7731686 | Devices, systems and methods for medicament delivery | Jun 10, 2026 | Kaleo Inc |
| Evzio (autoinjector) | US7731686 | Devices, systems and methods for medicament delivery | Jun 01, 2026 | Kaleo Inc |
| Evzio | US8926594 | Devices, systems and methods for medicament delivery | Mar 31, 2026 | Kaleo Inc |
| Evzio (autoinjector) | US8926594 | Devices, systems and methods for medicament delivery | Mar 31, 2026 | Kaleo Inc |
| Evzio | US9278182 | Devices, systems and methods for medicament delivery | Feb 01, 2026 | Kaleo Inc |
| Evzio (autoinjector) | US9278182 | Devices, systems and methods for medicament delivery | Feb 01, 2026 | Kaleo Inc |
| Evzio | US10335549 | Devices, systems and methods for medicament delivery | Apr 30, 2025 | Kaleo Inc |
| Evzio (autoinjector) | US10335549 | Devices, systems and methods for medicament delivery | Apr 30, 2025 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US10335549 | Devices, systems and methods for medicament delivery | Apr 30, 2025 | Kaleo Inc |
| Evzio | US8016788 | Devices, systems and methods for medicament delivery | Mar 21, 2025 | Kaleo Inc |
| Evzio (autoinjector) | US8016788 | Devices, systems and methods for medicament delivery | Mar 21, 2025 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US8016788 | Devices, systems and methods for medicament delivery | Mar 21, 2025 | Kaleo Inc |
| Evzio | US7731690 | Devices, systems and methods for medicament delivery | Jan 15, 2025 | Kaleo Inc |
| Evzio (autoinjector) | US7731690 | Devices, systems and methods for medicament delivery | Jan 15, 2025 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US7731690 | Devices, systems and methods for medicament delivery | Jan 15, 2025 | Kaleo Inc |
| Evzio | US10314977 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US10737028 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US7918823 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US8313466 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US8361029 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US8425462 | Devices, systems, and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US8608698 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US9056170 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio | US9737669 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US10314977 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US10737028 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US7918823 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US8313466 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US8361029 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US8425462 | Devices, systems, and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US8608698 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US9056170 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Evzio (autoinjector) | US9737669 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US10314977 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US10737028 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US7918823 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US8313466 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US8361029 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US8425462 | Devices, systems, and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US8608698 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US9056170 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
| Naloxone Hydrochloride (autoinjector) | US9737669 | Devices, systems and methods for medicament delivery | Nov 23, 2024 | Kaleo Inc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Naloxone Hydrochloride's patents.
Latest Legal Activities on Naloxone Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Naloxone Hydrochloride.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Patent Issue Date Used in PTA Calculation Critical | 07 Nov, 2023 | US11806428 |
| Mail Patent eGrant Notification | 07 Nov, 2023 | US11806428 |
| Recordation of Patent eGrant | 07 Nov, 2023 | US11806428 |
| Recordation of Patent Grant Mailed Critical | 07 Nov, 2023 | US11806428 |
| Patent eGrant Notification | 07 Nov, 2023 | US11806428 |
| Email Notification Critical | 07 Nov, 2023 | US11806428 |
| Email Notification Critical | 19 Oct, 2023 | US11806428 |
| Issue Notification Mailed Critical | 18 Oct, 2023 | US11806428 |
| Application Is Considered Ready for Issue Critical | 04 Oct, 2023 | US11806428 |
| Dispatch to FDC | 04 Oct, 2023 | US11806428 |
Naloxone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Naloxone Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Naloxone Hydrochloride. The first generic version for Naloxone Hydrochloride was by Wyeth Ayerst Laboratories and was approved on Sep 24, 1986. And the latest generic version is by Amneal Pharmaceuticals Llc and was approved on Apr 23, 2024.
Given below is the list of companies who have filed for Naloxone Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ABRAXIS PHARM
Abraxis Pharmaceutical Products has filed for 3 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 17, 1986 |
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 17, 1986 |
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Dec 16, 1988 |
2. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Oct 26, 2022 |
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Oct 26, 2022 |
3. AMNEAL
Amneal Pharmaceuticals Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG/SPRAY | spray, metered | Over the counter | NASAL | N/A | Apr 23, 2024 |
Manufacturing Plant Locations New
Amneal's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Amneal as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
4. ASTRAZENECA
Astrazeneca Lp has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Astrazeneca.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Apr 11, 1989 |
Manufacturing Plant Locations New
Astrazeneca's manufacturing plants are situated in 5 countries - Sweden, France, Germany, United States, Netherlands. Given below are the details of these plant locations as well as the firm names of Astrazeneca as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sweden |
| |||||||||||||||||||||||
| France |
| |||||||||||||||||||||||
| Germany |
| |||||||||||||||||||||||
| United States |
| |||||||||||||||||||||||
| Netherlands |
| |||||||||||||||||||||||
5. BAXTER HLTHCARE CORP
Baxter Healthcare Corp has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Baxter Hlthcare Corp.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Nov 7, 2022 |
6. BPI LABS
Bpi Labs Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Bpi Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Oct 6, 2023 |
Manufacturing Plant Locations New
Bpi Labs's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bpi Labs as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
7. BRISTOL MYERS SQUIBB
Bristol Myers Squibb Pharma Co has filed for 2 different strengths of generic version for Naloxone Hydrochloride. All of these versions come by the name NARCAN. Given below are the details of the strengths of this generic introduced by Bristol Myers Squibb.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Jul 28, 1988 |
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Jul 28, 1988 |
Manufacturing Plant Locations New
Bristol Myers Squibb's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Bristol Myers Squibb as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
8. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Dec 17, 2018 |
9. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Mar 16, 2020 |
10. ENDO OPERATIONS
Endo Operations Ltd has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Endo Operations.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Jul 29, 2022 |
11. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Nov 4, 2019 |
| 1MG/ML | injectable | Prescription | INJECTION | AP | Jan 14, 2021 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
12. FRESENIUS KABI USA
Fresenius Kabi Usa Llc has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Apr 2, 2024 |
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Apr 2, 2024 |
Manufacturing Plant Locations New
Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
13. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 3 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Mar 7, 2024 |
| 1MG/ML | injectable | Prescription | INJECTION | AP | Jun 10, 2022 |
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | May 24, 1988 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||
| Portugal |
| |||||||||
| Jordan |
| |||||||||
14. HOSPIRA
Hospira Inc has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML
(reference standard) | injectable | Prescription | INJECTION | AP | Jan 7, 1987 |
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Jan 16, 1987 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
15. IGI LABS INC
Igi Laboratories Inc has filed for 3 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Igi Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Apr 11, 1989 |
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Apr 11, 1989 |
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Apr 11, 1989 |
16. INTL MEDICATION
International Medication Systems Ltd has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Intl Medication.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 24, 1986 |
| 1MG/ML | injectable | Discontinued | INJECTION | N/A | Apr 27, 1988 |
17. MANKIND PHARMA
Mankind Pharma Ltd has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Feb 29, 2024 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
18. MARSAM PHARMS LLC
Marsam Pharmaceuticals Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Marsam Pharms Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Jul 19, 1988 |
19. MYLAN INSTITUTIONAL
Mylan Institutional Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Institutional.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Jun 29, 2016 |
Manufacturing Plant Locations New
Mylan Institutional's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Mylan Institutional as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
20. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 1MG/ML | injectable | Prescription | INJECTION | AP | Jun 9, 2022 |
21. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG/SPRAY | spray, metered | Over the counter | NASAL | N/A | Jun 21, 2022 |
Manufacturing Plant Locations New
Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Israel |
| |||
22. PAR STERILE PRODUCTS
Par Sterile Products Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Par Sterile Products.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Jan 17, 2020 |
Manufacturing Plant Locations New
Par Sterile Products's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Par Sterile Products as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
23. RISING
Rising Pharma Holdings Inc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Mar 14, 2017 |
Manufacturing Plant Locations New
Rising's manufacturing plants are situated in 3 countries - United States, Mexico, India. Given below are the details of these plant locations as well as the firm names of Rising as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||
| Mexico |
| |||||||||||||||||||
| India |
| |||||||||||||||||||
24. SMITH AND NEPHEW
Smith And Nephew Solopak Div Smith And Nephew has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Smith And Nephew.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 17, 1987 |
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 17, 1987 |
Manufacturing Plant Locations New
Smith And Nephew's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Smith And Nephew as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
25. SOLOPAK
Solopak Medical Products Inc has filed for 2 different strengths of generic version for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Solopak.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 17, 1987 |
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 17, 1987 |
26. SOMERSET THERAPS LLC
Somerset Therapeutics Llc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Prescription | INJECTION | AP | Aug 8, 2017 |
27. TEVA PHARMS USA
Teva Pharmaceuticals Usa Inc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG/SPRAY | spray, metered | Over the counter | NASAL | N/A | Apr 19, 2019 |
28. WATSON LABS
Watson Laboratories Inc has filed for 1 generic for Naloxone Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Nov 18, 1987 |
29. WYETH AYERST
Wyeth Ayerst Laboratories has filed for 2 different strengths of generic version for Naloxone Hydrochloride. All of these versions come by the name NALOXONE. Given below are the details of the strengths of this generic introduced by Wyeth Ayerst.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.02MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 24, 1986 |
| 0.4MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 24, 1986 |